Veeva Systems Inc. provides industry-specific cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. The company’s solutions enable pharmaceutical and other life sciences companies to realize the benefits of cloud-based architectures and mobile applications for various business functions. Its industry cloud solutions include Veeva CRM for customer relationship management that enables physician-facing employees, such as pharmaceutical sales representatives, key account managers, and scientific liaisons to manage, track, and optimize interactions with healthcare providers in various communication channels utilizing a single ...
4637 Chabot Drive
Pleasanton, CA 94588
Founded in 2007
Veeva Systems Inc. Announces Board Changes
Jul 10 14
Veeva Systems Inc. announced changes to its Board of Directors with the appointment of industry veteran Paul Sekhri. Concurrently, directors Young Sohn and Kevin Spain stepped down. Sekhri brings more than 25 years of experience in life sciences, having served in executive leadership positions at some of the most widely regarded pharmaceutical companies in the world, including Novartis, Teva, and Sanofi. Gordon Ritter, founder and general partner of Emergence Capital, remains Veeva Systems' chairman of the board. Sekhri is senior vice president, Integrated Care at Sanofi. Sekhri previously led global business development and was chief strategy officer at Teva.
Veeva Systems Introduces Commercial Cloud for Life Sciences
Jun 3 14
Veeva Systems unveiled Commercial Cloud - a next-generation solution to redefine how life sciences companies go to market. Veeva Commercial Cloud brings together the data, content, and interactions needed to deliver a fully informed, coordinated customer experience while ensuring compliance. Orchestrating resources and channels in a fundamentally new way, Veeva Commercial Cloud delivers the interoperability, agility, and continuous innovation needed for faster time-to-market and responsiveness to industry and regulatory changes. Veeva Commercial Cloud builds on a foundation of best-in-class solutions and unifies multichannel Veeva CRM, Veeva Network customer master, and Veeva Vault for regulated content management. Veeva Commercial Cloud advances the life sciences urgent drive for global harmonisation with technology that's tailored to local needs, and establishes an enterprise-wide platform for increased efficiencies and cost savings. Whether used regionally or globally, the Commercial Cloud supports commercial operations, end-to-end, for organizations of all sizes. The company also announced it is expanding Veeva Commercial Cloud with the addition of more communication channels for multichannel CRM and new offerings, including: Veeva Align to align resources to customers across all channels and define multichannel plans of action in a single country or worldwide. It increases the speed, flexibility, and accuracy of resource planning and alignment, ensuring resources are directed where they will have the impact. Veeva CRM Meetings for the planning, management, and execution of group meetings with healthcare professionals (HCPs). A single, global solution, Veeva Meetings simplifies meetings management and provides the spend visibility necessary to meet transparency reporting requirements. Veeva CRM Engage is a digital platform for engaging with customers online, anytime, anywhere, through any device. Now HCPs can have self-service access to personalised information via the web with interactive content and services like 'click-to-chat' and 'schedule a visit.' Veeva Engage brings digital into a fully integrated multichannel mix and enables reuse of content from other channels including Veeva CLM. Veeva CRM Co-browse is an online collaboration solution for real-time screen sharing with customers. Veeva Co-browse allows call centre, medical affairs, and field staff to collaborate and share content with customers online in a compliant way, and automatically captures all interaction details. Veeva Co-browse leverages content from Veeva CLM to maximise return on investment. Veeva CRM Engage is available on June 3, 2014. Veeva CRM Co-browse is planned for general availability in fourth quarter of 2014; Veeva Align and Veeva CRM Meetings are planned for second quarter of 2015.
Veeva Systems Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended April 30, 2014 ; Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal 2015
May 29 14
Veeva Systems Inc. announced unaudited consolidated earnings results for first quarter ended April 30, 2014. For the quarter, the company reported total revenues of $66,721,000, operating income of $12,557,000, income before income taxes of $12,527,000, net income attributable to class a and class b common stockholders, basic and diluted of $7,128,000 or $0.05 per diluted share, net cash provided by operating activities of $18,130,000, purchases of property and equipment of $299,000, non-GAAP operating income of $16,205,000, non-GAAP net income attributable to common stockholders of $10,245,000 or $0.07 per diluted share compared to the total revenues of $42,788,000, operating income of $8,173,000, income before income taxes of $7,674,000, net income attributable to class a and class b common stockholders, basic and diluted of $926,000 or $0.03 per diluted share, net cash provided by operating activities of $13,023,000, purchases of property and equipment of $217,000, non-GAAP operating income of $9,012,000, non-GAAP net income attributable to common stockholders of $5,451,000 or $0.05 per diluted share for the same quarter a year ago.
The company provided earnings guidance for the fiscal second quarter ending July 31, 2014. For the second quarter of fiscal 2015, the company expected total revenues between $68.5 and $69.5 million, non-GAAP operating income between $15 and $16 million and non-GAAP fully diluted net income per share of $0.07.
For the fiscal year ending January 31, 2015, the company expected total revenues between $277 and $282 million, non-GAAP operating income between $58 and $63 million and non-GAAP fully diluted net income per share between $0.26 and $0.28.